Atlas Trials

Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

Clinical trial NCT04216550 · UNKNOWN

Trial details

NCT number
NCT04216550
Sponsor
The First Affiliated Hospital of Zhengzhou University
Status
UNKNOWN
Study type
OBSERVATIONAL
Recurrent Glioma
Start date
2018-01-01
Primary completion
2025-01-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.